Johnson & Johnson EBIT 2010-2024 | JNJ

Johnson & Johnson EBIT for the quarter ending December 31, 2024 was $4.305B, a 19.38% decline year-over-year.

  • Johnson & Johnson 2024 EBIT was 18.774B, a 9.82% increase from 2023.
  • Johnson & Johnson 2023 EBIT was 17.095B, a 15.06% decline from 2022.
  • Johnson & Johnson 2022 EBIT was 20.125B, a 3.66% increase from 2021.

EBIT can be defined as earnings before interest and taxes.

Johnson & Johnson EBIT 2010-2024 | JNJ

  • Johnson & Johnson 2024 EBIT was 18.774B, a 9.82% increase from 2023.
  • Johnson & Johnson 2023 EBIT was 17.095B, a 15.06% decline from 2022.
  • Johnson & Johnson 2022 EBIT was 20.125B, a 3.66% increase from 2021.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B